CAREDX, INC. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
CAREDX, INC. (CDNA) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $10.62 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-07-30
- CAREDX, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $10.62M, a 12.89% increase year-over-year.
- CAREDX, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $9.77M, a 9.61% increase year-over-year.
- CAREDX, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $8.39M, a 50.34% decline year-over-year.
- CAREDX, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $9.40M, a 42.49% decline year-over-year.
- CAREDX, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $34.77M, a 47.53% decline from fiscal 2024.
- CAREDX, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $66.27M, a 35.50% increase from fiscal 2023.
- CAREDX, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $48.91M, a 5.85% increase from fiscal 2022.
- CAREDX, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $46.21M, a 28.98% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month as first filed | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10.62M 10-Q · filed 2026-07-30 | $20.38M derived: sum of 2 quarters · filed 2026-07-30 | ||||
| 2026-03-31 | $9.77M 10-Q · filed 2026-07-30 | |||||
| 2025-12-31 | $34.77M 10-K · filed 2026-02-25 | |||||
| 2025-09-30 | $8.39M 10-Q · filed 2025-11-04 | $17.80M derived: sum of 2 quarters · filed 2026-07-30 | $26.71M derived: sum of 3 quarters · filed 2026-07-30 | $43.20M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-06-30 | $9.40M 10-Q · filed 2026-07-30 | $18.31M derived: sum of 2 quarters · filed 2026-07-30 | $34.80M derived: sum of 3 quarters · filed 2026-07-30 | $51.71M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-03-31 | $8.91M 10-Q · filed 2026-07-30 | $25.40M derived: sum of 2 quarters · filed 2026-07-30 | $42.30M derived: sum of 3 quarters · filed 2026-07-30 | $58.65M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2024-12-31 | $16.49M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $33.39M derived: sum of 2 quarters · filed 2026-02-25 | $49.74M derived: sum of 3 quarters · filed 2026-02-25 | $66.27M 10-K · filed 2026-02-25 | ||
| 2024-09-30 | $16.90M 10-Q · filed 2025-11-04 | $13.67M 10-Q · filed 2024-11-04 | $33.25M derived: sum of 2 quarters · filed 2025-11-04 | $49.78M 10-Q · filed 2025-11-04 | ||
| 2024-06-30 | $16.35M 10-Q · filed 2025-11-04 | $13.12M 10-Q · filed 2024-07-31 | $32.88M 10-Q · filed 2025-08-06 | |||
| 2024-03-31 | $16.52M 10-Q · filed 2025-11-04 | $13.29M 10-Q · filed 2024-05-09 | ||||
| 2023-12-31 | $48.91M 10-K · filed 2026-02-25 | |||||
| 2023-09-30 | $12.62M 10-Q · filed 2024-11-04 | $25.28M derived: sum of 2 quarters · filed 2024-11-04 | $39.00M derived: sum of 3 quarters · filed 2024-11-04 | |||
| 2023-06-30 | $12.66M 10-Q · filed 2024-11-04 | $26.38M derived: sum of 2 quarters · filed 2024-11-04 | ||||
| 2023-03-31 | $13.72M 10-Q · filed 2024-11-04 | |||||
| 2022-12-31 | $46.21M 10-K · filed 2025-02-28 | |||||
| 2022-09-30 | $11.10M 10-Q · filed 2023-11-08 | $23.61M derived: sum of 2 quarters · filed 2023-11-08 | $34.17M derived: sum of 3 quarters · filed 2023-11-08 | |||
| 2022-06-30 | $12.51M 10-Q · filed 2023-11-08 | $23.08M derived: sum of 2 quarters · filed 2023-11-08 | ||||
| 2022-03-31 | $10.56M 10-Q · filed 2023-11-08 | |||||
| 2021-12-31 | $35.83M 10-K · filed 2024-02-28 | |||||
| 2021-09-30 | $10.57M 10-Q · filed 2022-11-03 | $19.90M derived: sum of 2 quarters · filed 2022-11-03 | $26.38M derived: sum of 3 quarters · filed 2022-11-03 | |||
| 2021-06-30 | $9.32M 10-Q · filed 2022-11-03 | $15.81M derived: sum of 2 quarters · filed 2022-11-03 | ||||
| 2021-03-31 | $6.49M 10-Q · filed 2022-11-03 | |||||
| 2020-12-31 | $23.05M 10-K · filed 2023-02-27 | |||||
| 2020-09-30 | $6.65M 10-Q · filed 2021-10-28 | $12.97M derived: sum of 2 quarters · filed 2021-10-28 | $17.17M derived: sum of 3 quarters · filed 2021-10-28 | |||
| 2020-06-30 | $6.32M 10-Q · filed 2021-10-28 | $10.52M derived: sum of 2 quarters · filed 2021-10-28 | ||||
| 2020-03-31 | $4.20M 10-Q · filed 2021-10-28 | |||||
| 2019-12-31 | $22.20M 10-K · filed 2022-02-24 | |||||
| 2019-09-30 | $5.91M 10-Q · filed 2020-10-29 | $10.85M derived: sum of 2 quarters · filed 2020-10-29 | $16.85M derived: sum of 3 quarters · filed 2020-10-29 | |||
| 2019-06-30 | $4.94M 10-Q · filed 2020-10-29 | $10.94M derived: sum of 2 quarters · filed 2020-10-29 | ||||
| 2019-03-31 | $6.00M 10-Q · filed 2020-10-29 | |||||
| 2018-09-30 | $1.20M 10-Q · filed 2019-10-31 | $3.65M derived: sum of 2 quarters · filed 2019-10-31 | $4.29M derived: sum of 3 quarters · filed 2019-10-31 | |||
| 2018-06-30 | $2.45M 10-Q · filed 2019-10-31 | $3.08M derived: sum of 2 quarters · filed 2019-10-31 | ||||
| 2018-03-31 | $634.00K 10-Q · filed 2019-10-31 | |||||
| 2017-12-31 | $1.49M 10-K · filed 2020-02-28 | |||||
| 2016-12-31 | $1.69M 10-K · filed 2019-03-06 | |||||
| 2015-12-31 | $1.34M 10-K · filed 2018-03-22 | $1.34M 10-K · filed 2016-03-29 | ||||
| 2014-12-31 | $535.00K 10-K · filed 2017-04-21 | |||||
| 2013-12-31 | $72.00K 10-K · filed 2016-03-29 | |||||
| 2012-12-31 | $69.00K 10-K · filed 2015-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |